INS and type 2 diabetes mellitus: A small scale prospective study of type 2 diabetic patients undergoing autologous bone marrow stem cell transplantation on the treatment of insulin-dependent type 2 DM with severe progressive insulin dysfunction showed promising results on the safety of the stem cell protocol and a noticeable reduction of insulin requirements.